UBS’s HANSEN MEDICAL, INC. COM NEW HNSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$15K Buy
1,270
+235
+23% +$2.84K ﹤0.01% 8412
2014
Q2
$14K Sell
1,035
-18,778
-95% -$326K ﹤0.01% 8568
2014
Q1
$515K Buy
19,813
+18,139
+1,084% +$407K ﹤0.01% 4201
2013
Q4
$29K Buy
1,674
+754
+82% +$14K ﹤0.01% 7706
2013
Q3
$16K Sell
920
-2,583
-74% -$40.6K ﹤0.01% 8348
2013
Q2
$50K Buy
+3,503
New +$62.2K ﹤0.01% 6751

Other funds holding HNSN

UBS's HNSN Position: Q3 2014 in Review

UBS increased its HANSEN MEDICAL, INC. COM NEW (HNSN) stake by 23% in Q3 2014, buying an estimated $2.84K and bringing the position to 1,270 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #8412.

UBS first reported a position in HNSN in Q2 2013 and has held it in 6 quarters since. The position peaked at $515K in Q1 2014. 53 funds tracked by Wall St. Rank hold HNSN as of Q3 2014.

  • UBS held 1,270 shares of HANSEN MEDICAL, INC. COM NEW worth $15K as of Q3 2014.
  • UBS bought 235 HANSEN MEDICAL, INC. COM NEW shares in Q3 2014, an estimated $2.84K.
  • HANSEN MEDICAL, INC. COM NEW made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8412 holding.
  • UBS first reported a position in HANSEN MEDICAL, INC. COM NEW in Q2 2013 and has held it in 6 quarters since.
  • UBS's HANSEN MEDICAL, INC. COM NEW position peaked at $515K in Q1 2014.
  • 53 funds tracked by Wall St. Rank held HANSEN MEDICAL, INC. COM NEW as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.